CVS Group plc (LON:CVSG) Stock Has Consensus Price Target of GBX 1,666.67 According to Brokerages

Shares of CVS Group plc (LON:CVSG) have received an average recommendation of “Moderate Buy” from the six research firms that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is GBX 1,666.67.

CVSG has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 1,700 price objective on shares of CVS Group in a research report on Monday, July 27th. Jefferies Financial Group restated a “hold” rating and set a GBX 1,400 target price on shares of CVS Group in a research note on Friday, September 25th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 2,000 target price on shares of CVS Group in a report on Thursday, September 24th. Finally, Shore Capital Group reiterated a “hold” rating and issued a GBX 1,400 price target on shares of CVS Group in a research note on Thursday, September 24th.

Insider Activity

In other news, insider Joanne Shaw bought 1,592 shares of the firm’s stock in a transaction dated Monday, August 10th. The shares were bought at an average price of GBX 1,287 per share, with a total value of £20,489.04. Also, insider Robin Alfonso bought 768 shares of the stock in a transaction dated Thursday, August 6th. The shares were purchased at an average price of GBX 1,294 per share, for a total transaction of £9,937.92. Over the last quarter, insiders have bought 3,860 shares of company stock valued at $4,956,696. 1.48% of the stock is owned by insiders.

CVS Group Stock Performance

CVSG opened at GBX 1,176 on Thursday. The company has a quick ratio of 0.90, a current ratio of 1.18 and a debt-to-equity ratio of 110.41. CVS Group has a 12-month low of GBX 1,062 and a 12-month high of GBX 1,648. The business has a 50 day moving average of GBX 1,283.30 and a 200-day moving average of GBX 1,228.61. The stock has a market cap of £799.33 million, a price-to-earnings ratio of 17.07, a PEG ratio of 1.77 and a beta of 1.07.

CVS Group (LON:CVSG) last posted its earnings results on Thursday, September 24th. The company reported GBX 85.60 earnings per share for the quarter. CVS Group had a return on equity of 5.91% and a net margin of 2.43%. On average, equities research analysts expect that CVS Group will post 93.9393939 earnings per share for the current year.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.